Strength of clinical indication and therapeutic impact of the implantable cardioverter defibrillator in patients with hypertrophic cardiomyopathy.
Fumagalli C, De Filippo V, Zocchi C, Tassetti L, Marra MP, Brunetti G, Baritussio A, Cipriani A, Bauce B, Carrassa G, Maurizi N, Zampieri M, Calore C, De Lazzari M, Berteotti M, Pieragnoli P, Corrado D, Olivotto I.
Fumagalli C, et al. Among authors: calore c.
Int J Cardiol. 2022 Apr 15;353:62-67. doi: 10.1016/j.ijcard.2022.01.022. Epub 2022 Jan 12.
Int J Cardiol. 2022.
PMID: 35031346